2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$37.39-$0.71 (-1.86%)
Price as of Jun 23, 2026 5:08 PM EDT- $7.8BMarket Cap
- 146.28%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$37.39-$0.71 (-1.86%)
IMVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.10 | ||
Change | +$2.76 (+7.81%) | ||
Open | $36.43 | ||
High | $38.74 | ||
Low | $35.95 | ||
Previous Close | $35.34 | ||
Volume | 2,808,164 | ||
30-Day Average Volume | 1,709,905 | ||
1-Week Change | 13.94% | ||
1-Month Change | 11.57% | ||
1-Year Change | 146.28% | ||
3-Year Change | 85.85% | ||
5-Year Change | 243.55% | ||
Fundamentals | |||
Shares Outstanding | 205.3M | ||
Total Assets | $957.0M | ||
Market Cap | $7.8B | ||
Enterprise Value | $6.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$147.9M | ||
Free Cash Flow | -$95.1M | ||
EBIT | -$150.7M | ||
EBITDA | -$150.6M | ||
Net Working Capital | $844.4M | ||
EPS | -$0.72 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 9 | ||
P/E | -53 | ||
PEG | 3 | ||
Price/Free Cash Flow | -82 | ||
Price/Operating Cash Flow | -82 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue